ストックスクリーナーアプリを入手
0.7884
2.01%
0.0155
アフターアワーズ：
.80
0.0116
+1.47%
Immunic Inc (IMUX) 最新ニュース
Immunic Therapeutics reaches major milestone with completion of ENSURE Trial Enrollment - Proactive Investors
Immunic at Jefferies Conference: Promising MS Drug Insights - Investing.com Australia
Small cap wrap: Midnight Sun Mining, Standard Uranium, Immunic, ReconAfrica... - Proactive financial news
Market movers: Tesla, Verint, PVH, Immunic... - Proactive financial news
Immunic (IMUX) Receives Continued 'Buy' Rating from D. Boral Cap - GuruFocus
Immunic completes patient enrollment in Phase 3 relapsing multiple sclerosis trials - Proactive financial news
Immunic Completes Enrollment in 2 Phase 3 Studies in Relapsing Multiple Sclerosis - marketscreener.com
IMUX: Promising Results of Vidofludimus Calcium in Multiple Sclerosis Treatment | IMUX Stock News - GuruFocus
IMUX Completes Enrollment for Phase 3 Trials in Multiple Scleros - GuruFocus
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS | IMUX S - GuruFocus
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS - Yahoo Finance
Top Executives Make Bold Moves with Major Immunic Stock Purchases! - TipRanks
Immunic Approves Equity Plan Amendment at Annual Meeting - TipRanks
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering | IMUX Stock News - GuruFocus
Immunic Announces Closing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - Longview News-Journal
Immunic raises $65M in public offering to fund clinical trials - Proactive financial news
Immunic to Participate in Investor, Scientific and Industry Conf - GuruFocus
Immunic Showcases Breakthrough MS Drug Data at 6 Major Healthcare Conferences This Month - Stock Titan
Immunic releases June conference schedule - Proactive Investors
Immunic Announces $65 Million Public Offering - TipRanks
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Eastern Progress
Immunic Inc. prices $65 million public offering By Investing.com - Investing.com South Africa
Immunic (NASDAQ:IMUX) Price Target Lowered to $10.00 at D. Boral Capital - Defense World
Immunic (IMUX) Launches $65M Public Offering, Shares Drop - GuruFocus
Immunic Tumbles After Pricing $65 Million Offering of Warrants - marketscreener.com
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Un - GuruFocus
Small cap wrap: Fineqia, Synchronoss, Santacruz Silver, Immunic... - Proactive financial news
Immunic (IMUX) Receives Target Price Adjustment from D. Boral Ca - GuruFocus
Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering - GuruFocus
Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering | IMUX Stock News - GuruFocus
Immunic (IMUX) Launches Public Offering with Warrant Options | I - GuruFocus
Immunic shares fall 12% after pricing of $65 million underwritten public offering to fund trials - Seeking Alpha
Immunic to raise up to $65M in underwritten public offering - Proactive Investors
Immunic (IMUX) Launches Public Offering with Warrant Options | IMUX Stock News - GuruFocus
Immunic Announces Pricing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com
Immunic Inc. prices $65 million public offering - Investing.com
Immunic, Inc. Announces Proposed Public Offering - Longview News-Journal
Immunic Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Investing.com Nigeria
Immunic launches public offering of warrants to fund clinical trials; shares down - MSN
Immunic slides on planned equity raise - TradingView
Immunic (IMUX) Launches Public Offering with Pre-Funded and Warr - GuruFocus
Immunic announces public offering of warrants to fund trials - Investing.com India
Immunic announces public offering of warrants to fund trials By Investing.com - Investing.com Canada
Immunic (IMUX) Launches Public Offering with Pre-Funded and Warrants | IMUX Stock News - GuruFocus
Immunic Announces Public Offering to Fund Trials - TipRanks
Biotech Immunic Launches Strategic Public Offering to Advance Inflammatory Disease Pipeline - Stock Titan
Immunic's IMU-856 shows promise as Celiac Disease Awareness Month draws to a close - Proactive Investors
Immunic’s (IMUX) Buy Rating Reiterated at B. Riley - Defense World
Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic F - GuruFocus
Immunic (IMUX) Price Target Lowered by B. Riley Securities | IMU - GuruFocus
Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic Financing Prospects | IMUX Stock News - GuruFocus
B. Riley Cuts Price Target on Immunic to $5 From $6, Keeps Buy Rating - marketscreener.com
Janus Henderson Group PLC Cuts Stock Holdings in Immunic, Inc. (NASDAQ:IMUX) - Defense World
Immunic, Inc. (NASDAQ:IMUX) Receives $13.20 Average Price Target from Analysts - Defense World
Immunic: Q1 Earnings Snapshot - CT Insider
0.00%
2.33%
大文字化:
|
ボリューム (24 時間):